
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for ACM and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for ACM and 80,000+ other tickers.
See exactly how ACM's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ACM and 80,000+ other tickers.
AECOM, along with its affiliated entities, delivers specialized infrastructure consulting services to public sector bodies, private businesses, and various organizations across the globe, with operations spanning the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. The company manages its extensive operations through three distinct segments: Americas, International, and AECOM Capital. For its commercial and governmental clientele, AECOM offers a comprehensive suite of services including strategic planning, expert consultation, architectural and engineering design, and…

New capability delivers a 70% sulfuric acid recycle rate while maintaining stringent particle control; System validated across more than 50 process layers at a foundry customer New capability delivers a 70% sulfuric acid recycle rate while maintaining stringent particle control; System validated across more than 50 process layers at a foundry customer

New York, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Diamond Equity Research LLC, an equity research firm with a focus on small capitalization public companies has released an update report on Allied Critical Metals Inc. (CSE: ACM) (OTCQB: ACMIF) (FSE: 0VJ0). The research summary below is from a report commissioned by Allied Critical Metals Inc. and produced by Diamond Equity Research.

FREMONT, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- ACM Research, Inc. (“ACM”) (NASDAQ: ACMR) announced today that it will release its financial results for the third quarter of 2026 before the U.S. market open on Thursday, November 5, 2026.

ACM Research's China revenue grew 15.8% in 2025, despite a 0.5% decline in China's overall semiconductor equipment market. Revenue outside wafer cleaning surged approximately 160% in the first half of 2026, reaching 51.3% of consolidated sales.

NEW YORK, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO) a clinical stage company focused on reshaping the path of genetic diseases with high unmet need, today announced that it will host an educational investor event, “Assessing clinically meaningful arrhythmias in PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM)” on Wednesday, October 21, 2026 at 1:00 PM ET. The event will feature a discussion with Narinder Bhalla, M.D.